FIELD: pharmaceuticals.
SUBSTANCE: invention relates to the use of silver salts of methyl (2Z)-4-aryl-2-{4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]phenylamino}-4-oxobut-2-enoates of formula (I, II) as antibacterial drugs. The invention relates to the use of silver salts of methyl (2Z)-4-aryl-2-{4-[(4,6-dimethylpyrimidin-2-yl)sulfamoyl]phenylamino}-4-oxobut-2-enoates of the formula I, II in as antibacterial drugs.
EFFECT: these salts have low toxicity and can be used in medicine.
1 cl, 1 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| 4-(4-METHOXYPHENYL)-2-{2-[2-OXO-(3-CHLORO-ADAMANTAN-1-YL)-ETHYLIDENE]HYDRAZINYL}-4-OXOBUT-2-ENOATE SODIUM WITH HEMOSTATIC ACTIVITY | 2016 |
|
RU2663624C1 |
| SILVER SALTS OF 5,6-DIARYL-4-[4-(ACETYLAMINOSULPHONYL)PHENYL]-3,5-DIHYDROPYRROLO[3,4-C]PYRAZOL-3-ONES EXHIBITING ANTIMICROBIAL ACTIVITY | 2019 |
|
RU2698328C1 |
| APPLICATION OF THE SILVER SALT OF N-{4-[(1,3-THIAZOLE-2-YL)SULPHAMOYL]PHENYL}-1-PHENYL-5-(4-ETHOXYPHENYL)PYRAZOLE-3-CARBOXAMIDE AS AN ANTIFUNGAL AGENT AGAINST STRAINS OF C. TROPICALIS, C. KRUSEI, AND C. GLABRATA FUNGI | 2020 |
|
RU2763724C1 |
| METHOD FOR PRODUCING A BIOLOGICALLY ACTIVE SUBSTANCE HAVING ANTIBACTERIAL ACTIVITY, AND A SUBSTANCE OBTAINED BY THIS METHOD | 2022 |
|
RU2792376C1 |
| 2-{[2-(ADAMANTAN-1-YL)-2-OXOETHYLIDENEHYDRAZINYL-4-(Β-NAPHTHALYL)-4-OXOBUT-2-ENOYL]THIO} SODIUM ETHANOATE WITH WOUND HEALING AND ANTI-INFLAMMATORY ACTIVITY | 2023 |
|
RU2808431C1 |
| 3-BROMO-4-(4-METHOXYPHENYL)-N-(5-METHYL-1,3,4-THIADIAZOL-2-YL)-2,4-DIOXOBUTANAMIDE, HAVING ANTIMICROBIAL ACTION | 2018 |
|
RU2717243C2 |
| (2Z,5Z-1-ARYL-3-HYDROXY-5-(3,3-DIMETHYL-3,4-DIHYDROISOQUINOLIN-1(2N)-YLIDENE)-PENT-2-ENE-1,4-DIONES AND METHOD OF PRODUCING SAID COMPOUNDS | 2008 |
|
RU2374232C1 |
| SILVER SALTS OF 1-(4-HALOGENHENYL)-4,4,4-TRIFLUOROBUTANE-1,3-DIONES WITH ANTIMICROBIAL ACTIVITY | 2023 |
|
RU2798433C1 |
| SILVER SALTS OF 3,4-DIARYL-5-[4-(ACETYLAMINOSULPHONYL)PHENYL]-4,6-DIHYDROPYRROLO[3,4-C]PYRAZOL-6-ONES EXHIBITING ANTIFUNGAL ACTIVITY | 2018 |
|
RU2706357C1 |
| 2-HYDROXY-4-OXO-4-(4'-CHLOROPHENYL)-BUT-2-ENOAT 4-METHYL-2-PYRIDYLAMMONIUM THAT HAS A DIRECT ANTICOAGULANT ACTION | 2015 |
|
RU2649140C2 |
